Atomoxetine occupies the norepinephrine transporter in a dose-dependent fashion: a PET study in nonhuman primate brain using (S,S)-[18F]FMeNER-D2.
about
Cognitive enhancers for the treatment of ADHDAtomoxetine acts as an NMDA receptor blocker in clinically relevant concentrationsEvidence for the involvement of dopamine transporters in behavioral stimulant effects of modafinilfMRI of cocaine self-administration in macaques reveals functional inhibition of basal gangliaRelationship between atomoxetine plasma concentration, treatment response and tolerability in attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder.The neurobiology of modafinil as an enhancer of cognitive performance and a potential treatment for substance use disorders.Amphetamine decreases α2C-adrenoceptor binding of [11C]ORM-13070: a PET study in the primate brain.No Evidence for Association Between Norepinephrine Transporter-3081 (A/T) Polymorphism and Attention Deficit Hyperactivity Disorder in Iranian Population.The norepinephrine transporter in attention-deficit/hyperactivity disorder investigated with positron emission tomography.Guanfacine Extended Release: A New Pharmacological Treatment Option in Europe.Atomoxetine increases fronto-parietal functional MRI activation in attention-deficit/hyperactivity disorder: a pilot study.Atomoxetine Treatment Strengthens an Anti-Correlated Relationship between Functional Brain Networks in Medication-Naïve Adults with Attention-Deficit Hyperactivity Disorder: A Randomized Double-Blind Placebo-Controlled Clinical TrialEvaluation of [(11)C]MRB for assessment of occupancy of norepinephrine transporters: Studies with atomoxetine in non-human primatesClinically relevant doses of methylphenidate significantly occupy norepinephrine transporters in humans in vivo.Synthesis, radiosynthesis, and biological evaluation of carbon-11 and fluorine-18 labeled reboxetine analogues: potential positron emission tomography radioligands for in vivo imaging of the norepinephrine transporter.Atomoxetine affects transcription/translation of the NMDA receptor and the norepinephrine transporter in the rat brain--an in vivo study.Enhanced selective serotonin re-uptake inhibitors as antidepressants: 2004 - 2006.Fluorine-18 Radiolabeled PET Tracers for Imaging Monoamine Transporters: Dopamine, Serotonin, and Norepinephrine.Differential roles for cortical versus sub-cortical noradrenaline and modulation of impulsivity in the rat.Kinetic modeling and occupancy measures of the norepinephrine transporters in baboons using single photon emission computed tomography with (123)I-INER.Pharmacodynamics of norepinephrine reuptake inhibition: Modeling the peripheral and central effects of atomoxetine, duloxetine, and edivoxetine on the biomarker 3,4-dihydroxyphenylglycol in humans.A regularized full reference tissue model for PET neuroreceptor mapping.Iodine-123 labeled reboxetine analogues for imaging of noradrenaline transporter in brain using single photon emission computed tomography.Norepinephrine transporter occupancy in the human brain after oral administration of quetiapine XR.Effects of atomoxetine on subjective and neurocognitive symptoms of nicotine abstinence.SERT and NET occupancy by venlafaxine and milnacipran in nonhuman primates: a PET study.Norepinephrine transporter occupancy by nortriptyline in patients with depression: a positron emission tomography study with (S,S)-[¹⁸F]FMeNER-D₂.Boosting Norepinephrine Transmission Triggers Flexible Reconfiguration of Brain Networks at Rest.Differential long-term medication impact on executive function and delay aversion in ADHD.Bayesian hierarchical modeling of receptor occupancy in PET trials.NET occupancy by clomipramine and its active metabolite, desmethylclomipramine, in non-human primates in vivo.No evidence for association between a functional promoter variant of the Norepinephrine Transporter gene SLC6A2 and ADHD in a family-based sample
P2860
Q22251235-7282170A-8052-4547-B377-DE7F0783F381Q24607931-18643262-CFBE-435C-A96F-07207A28BB15Q24655278-8DD92506-073D-4537-94A7-C5D5703E52D8Q30473348-E9BD2010-6F88-4EA6-BE53-B090211CDA15Q33722310-A1359850-F0CC-418B-A92E-39A4564BE068Q34363257-7BB7BE2E-06CA-4FF4-AE6C-B4ED4A7F7A02Q35179039-94D85EBD-A4FF-4A29-B1A3-9710729E8005Q36095784-1FF03E9F-4F23-4D5F-B81E-BC4E6EABF8D0Q36424492-9A52BD3F-90B7-42E7-BBD5-60C6EFBE58E8Q36446854-33289994-86B3-49CD-8D17-95EBE7480502Q36570070-FB95D531-1250-4A63-A744-FB1B6AB1C3CEQ36749821-8B0F7862-7C83-47BF-95E7-4356AFDC3FDEQ37009798-734E1952-7A74-4B8E-85B9-74875AE34E16Q37091243-3BC58E17-9FD3-4CD5-9EDB-F2251CEBBAB0Q37352287-5E0F5FD2-DD7A-43BF-848D-6CF4DE89C2CAQ37378254-1F1D3890-5774-4302-AC37-6C73F517D46BQ37689787-3707841A-7F27-4C37-ADE9-4F74DEF68987Q37706110-3A1B2D8F-7786-4949-8E94-E073A6701CCBQ39287555-C61FBDF3-6ED2-4984-9A82-DA1E2704DFEFQ39540813-E66EB4F0-8F48-43E3-A27D-5097DE1EE311Q40901122-1CBFE79D-61FA-44FA-B36A-FD2CC29A49D4Q41654553-2A810E25-DEF8-4BA3-8484-BFC99B37895EQ45343175-C2A030F1-728E-4FE6-92F8-D91B61229645Q45786962-846B3E2D-B9DA-4410-BE2C-64B691884342Q46565103-E5942826-6E77-4178-A16F-12BFF534B805Q48325561-4B8658F2-9820-49AF-AAB8-C8C84CFB1CC6Q48385208-6C34FAB3-2EE5-467F-8C06-593775FDF490Q48527804-8C3EFC87-792A-4A58-A615-D362617D2B40Q49821724-D2B179D4-CBB1-47B0-88BB-FEFA2723D149Q51891389-A36D661D-0BD3-45B1-AE38-A8E5156AFF19Q55053974-C9D7A924-8E0B-4A76-9E94-43291603213BQ58408163-65556FD2-3226-40F7-8F02-E774ED9476D2
P2860
Atomoxetine occupies the norepinephrine transporter in a dose-dependent fashion: a PET study in nonhuman primate brain using (S,S)-[18F]FMeNER-D2.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Atomoxetine occupies the norep ...... in using (S,S)-[18F]FMeNER-D2.
@en
Atomoxetine occupies the norep ...... in using (S,S)-[18F]FMeNER-D2.
@nl
type
label
Atomoxetine occupies the norep ...... in using (S,S)-[18F]FMeNER-D2.
@en
Atomoxetine occupies the norep ...... in using (S,S)-[18F]FMeNER-D2.
@nl
prefLabel
Atomoxetine occupies the norep ...... in using (S,S)-[18F]FMeNER-D2.
@en
Atomoxetine occupies the norep ...... in using (S,S)-[18F]FMeNER-D2.
@nl
P2093
P1433
P1476
Atomoxetine occupies the norep ...... in using (S,S)-[18F]FMeNER-D2.
@en
P2093
Andrea Varrone
Balázs Gulyás
Francois Vandenhende
Johannes Tauscher
Lars Farde
Magnus Schou
Nicholas Seneca
Robert B Innis
William Kielbasa
P2860
P2888
P304
P356
10.1007/S00213-006-0483-3
P577
2006-08-04T00:00:00Z